Sign in
4

Changes in Ownership

Arcadia Biosciences, Inc. Filed Acc 0001209191-21-005218

Chief Technology Officer bought 700 shares at $3.16 ($2,212)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shultz Randall Chief Technology Officer 2020-08-03 Purchase +700 $3.16 $2,212 13,000 D
Derivatives
Shultz Randall Chief Technology Officer 2021-01-21 Grant or award · Stock Option (right to buy) +55,000 115,000 D
Open-market purchases · 700 sh · avg $3.16 · $2,212
Loading xslF345X03/doc4.xml…